At the time of writing, Maravai LifeSciences Holdings Inc [MRVI] stock is trading at $5.22, up 5.24%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MRVI shares have gain 18.10% over the last week, with a monthly amount drifted -26.79%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, William Blair downgraded its rating to Mkt Perform on November 08, 2024. On August 28, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $10 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and decreased its price target to $10 on August 13, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $15 as its price target on April 10, 2024. BofA Securities upgraded its rating to Buy for this stock on December 12, 2023, and downed its price target to $8. In a note dated August 08, 2023, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
For the past year, the stock price of Maravai LifeSciences Holdings Inc fluctuated between $4.28 and $11.56. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. Maravai LifeSciences Holdings Inc [NASDAQ: MRVI] shares were valued at $5.22 at the most recent close of the market. An investor can expect a potential return of 263.98% based on the average MRVI price forecast.
Analyzing the MRVI fundamentals
According to Maravai LifeSciences Holdings Inc [NASDAQ:MRVI], the company’s sales were 276.92M for trailing twelve months, which represents an -2.49% plunge. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at 1.59%, and Net Profit Margin reading is -0.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.56 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.99 points at the first support level, and at 4.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.38, and for the 2nd resistance point, it is at 5.55.
Ratios To Look Out For
It is important to note that Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] has a current ratio of 10.74. Further, the Quick Ratio stands at 9.94, while the Cash Ratio is 9.14. Considering the valuation of this stock, the price to sales ratio is 5.01, the price to book ratio is 2.14.
Transactions by insiders
Recent insider trading involved DeFord John A, Director, that happened on Nov 12 ’24 when 17500.0 shares were purchased., HULL CARL completed a deal on Nov 11 ’24 to buy 0.17 million shares. Meanwhile, Director GTCR INVESTMENT XI LLC sold 9.94 million shares on May 28 ’24.
